HIGHLIGHTS
- who: Kang Mi Lee and colleagues from the Center for TransplantationUniversity of of Pennsylvania, Philadelphia, Pennsylvania, USA have published the article: Authorship note: KML, QF, GH, and JFM contributed equally to this work. Conflict of interest: The authors have declared that no conflict of interest exists, in the Journal: (JOURNAL)
- what: As proof of concept for the potential of Bregs as a cell-based therapy, this study shows that naive B cells activated in_vitro through TLR signaling are able to fully suppress T_cell proliferation in_vitro and promote allograft tolerance in mice. Although the work has . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.